Badri N Dasu Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Badri N Dasu.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Badri N Dasu. Badri N Dasu is Chief Engineering Officer in ACELRX PHARMACEUTICALS INC ($ACRX).
Latest Insider Trading Transactions of Badri N Dasu
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 1.88 | 50,000 | 94,000 | 50,000 | |
| Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 1.88 | 100,000 | 188,000 | 100,000 | |
| Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Grant | A | 0.00 | 50,000 | 0 | 204,757 | 154.8 K to 204.8 K (+32.31 %) |
| Feb 12 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Payment of Exercise | F | 2.63 | 6,775 | 17,818 | 144,757 | 151.5 K to 144.8 K (-4.47 %) |
| Feb 09 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Payment of Exercise | F | 2.59 | 6,846 | 17,731 | 151,532 | 158.4 K to 151.5 K (-4.32 %) |
| Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 1.72 | 100,000 | 172,000 | 100,000 | |
| Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Grant | A | 0.00 | 50,000 | 0 | 163,267 | 113.3 K to 163.3 K (+44.14 %) |
| Nov 04 2019 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 2.23 | 31,625 | 70,366 | 63,250 | |
| Mar 04 2019 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Buy | P | 2.81 | 9,206 | 25,869 | 113,267 | 104.1 K to 113.3 K (+8.85 %) |
| Feb 13 2019 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 2.51 | 100,000 | 251,000 | 100,000 | |
| Feb 13 2019 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Grant | A | 0.00 | 50,000 | 0 | 104,061 | 54.1 K to 104.1 K (+92.49 %) |
| Nov 05 2018 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 2.23 | 31,625 | 70,366 | 31,625 | |
| Oct 16 2018 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Sell | S | 5.00 | 28,351 | 141,755 | 54,061 | 82.4 K to 54.1 K (-34.40 %) |
| Sep 05 2018 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Grant | A | 1.49 | 8,022 | 11,953 | 82,412 | 74.4 K to 82.4 K (+10.78 %) |
| Jan 26 2018 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 2.00 | 115,000 | 230,000 | 115,000 | |
| Jan 26 2018 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 2.00 | 115,000 | 230,000 | 115,000 | |
| Oct 20 2017 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | M | 1.20 | 37,500 | 45,000 | 0 | |
| Oct 20 2017 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Buy | M | 1.20 | 37,500 | 45,000 | 74,390 | 36.9 K to 74.4 K (+101.65 %) |
| Feb 09 2017 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 3.00 | 79,500 | 238,500 | 79,500 | |
| Feb 18 2016 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 3.40 | 70,000 | 238,000 | 70,000 | |
| Mar 06 2012 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Payment of Exercise | F | 2.91 | 1,511 | 4,397 | 12,006 | 13.5 K to 12 K (-11.18 %) |
| Feb 09 2012 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 3.39 | 51,319 | 173,971 | 51,319 | |
| Sep 08 2011 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Payment of Exercise | F | 3.10 | 1,354 | 4,197 | 13,517 | 14.9 K to 13.5 K (-9.10 %) |
| Mar 04 2011 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 3.45 | 40,000 | 138,000 | 40,000 | |
| Mar 04 2011 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 3.45 | 12,500 | 43,125 | 12,500 | |
| Mar 04 2011 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Grant | A | 0.00 | 14,871 | 0 | 14,871 | 0 to 14.9 K |
Page: 1